Pramipexole Dihydrochloride Patent Expiration
Pramipexole Dihydrochloride is Used for treating moderate to severe primary Restless Legs Syndrome (RLS). It was first introduced by Boehringer Ingelheim
Pramipexole Dihydrochloride Patents
Given below is the list of patents protecting Pramipexole Dihydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mirapex Er | US8679533 | Pramipexole once-daily dosage form | Sep 08, 2029 | Boehringer Ingelheim |
| Mirapex Er | US7695734 | Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof | Apr 26, 2028 | Boehringer Ingelheim |
| Mirapex | US6001861 | Use of pramipexole in the treatment of restless legs syndrome |
Jan 16, 2018
(Expired) | Boehringer Ingelheim |
| Mirapex | US6194445 | Use of pramipexole in the treatment of restless legs syndrome |
Jan 16, 2018
(Expired) | Boehringer Ingelheim |
Pramipexole Dihydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List